Arthritis Research UK Gout Treatment Trial - Phase 2
The purpose of this study is to determine in community-derived patients with gout the effectiveness, and cost effectiveness, of a nurse-led complex intervention that reflects recommended best practice (including patient information concerning gout, its prognosis and its non-pharmacological and drug options).
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Arthritis Research UK Gout Treatment Trial. Phase 2: Two Year Randomised Controlled Trial of a Nurse Led Package of Care|
- Reduction in serum uric acid levels [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- Reduction in number of self reported acute attacks during year 2 [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- Improved Quality of Life scores at study end [ Time Frame: 2 years ] [ Designated as safety issue: No ]
|Study Start Date:||March 2013|
|Estimated Study Completion Date:||October 2016|
|Estimated Primary Completion Date:||October 2016 (Final data collection date for primary outcome measure)|
Nurse led package of care based on current recommended best practice.
Other: Nurse intervention
Complex package of care involving patient information and advice concerning lifestyle modification and recommended drug therapy.
Continuing standard general practitioner led care
Other: Standard care
Continuing standard General Practitioner led care.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01477346
|Academic Rheumatology, University of Nottingham|
|Nottingham, United Kingdom, NG5 1PB|
|Principal Investigator:||Michael Doherty, MA MD FRCP||University of Nottingham|